<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(1)</volume><submitter>Kim H</submitter><pubmed_abstract>Aluminium hydroxide is a well-known adjuvant used in vaccines. Although it can enhance an adaptive immune response to a co-administered antigen, it causes adverse effects, including macrophagic myofasciitis (MMF), subcutaneous pseudolymphoma, and drug hypersensitivity. The object of this study is to demonstrate pediatric cases of aluminium hydroxide-induced diseases focusing on its rarity, under-recognition, and distinctive pathology. Seven child patients with biopsy-proven MMF were retrieved from the Seoul National University Hospital (SNUH) pathology archives from 2015 to 2019. The medical records and immunisation history were reviewed, and a full pathological muscle examination was carried out. The mean age was 1.7 years (8.9-40 months), who had records of vaccination against hepatitis </pubmed_abstract><journal>Scientific reports</journal><pagination>11834</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7366910</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Macrophagic myofasciitis and subcutaneous pseudolymphoma caused by aluminium adjuvants.</pubmed_title><pmcid>PMC7366910</pmcid><pubmed_authors>Park JW</pubmed_authors><pubmed_authors>Lim KY</pubmed_authors><pubmed_authors>Kim H</pubmed_authors><pubmed_authors>Park SH</pubmed_authors><pubmed_authors>Kang J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Macrophagic myofasciitis and subcutaneous pseudolymphoma caused by aluminium adjuvants.</name><description>Aluminium hydroxide is a well-known adjuvant used in vaccines. Although it can enhance an adaptive immune response to a co-administered antigen, it causes adverse effects, including macrophagic myofasciitis (MMF), subcutaneous pseudolymphoma, and drug hypersensitivity. The object of this study is to demonstrate pediatric cases of aluminium hydroxide-induced diseases focusing on its rarity, under-recognition, and distinctive pathology. Seven child patients with biopsy-proven MMF were retrieved from the Seoul National University Hospital (SNUH) pathology archives from 2015 to 2019. The medical records and immunisation history were reviewed, and a full pathological muscle examination was carried out. The mean age was 1.7 years (8.9-40 months), who had records of vaccination against hepatitis </description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jul</publication><modification>2025-04-29T10:49:37.297Z</modification><creation>2025-04-06T19:38:34.113Z</creation></dates><accession>S-EPMC7366910</accession><cross_references><pubmed>32678281</pubmed><doi>10.1038/s41598-020-68849-8</doi></cross_references></HashMap>